A PHLDB1 variant associated with the nonfunctional pituitary adenoma

Area of Science:

• Genetics
• Oncology
• Endocrinology

Background:

• Previous studies linked PHLDB1 single-nucleotide polymorphisms (SNPs) to glioma risk.
• The association between PHLDB1 SNPs and pituitary adenoma risk remained uninvestigated.

Purpose of the Study:

• To evaluate the association between PHLDB1 SNPs and the risk of developing pituitary adenomas.
• Specifically investigate the link between PHLDB1 genetic variants and nonfunctional pituitary adenoma (NFPA) risk.

Main Methods:

• A case-control study was conducted in the Korean population.
• Genotyped 27 PHLDB1 tagging and exon SNPs in 148 NFPA patients and 375 controls.
• Logistic regression analysis was employed to assess the association between PHLDB1 SNPs and NFPA risk.

Main Results:

• A significant association was detected between a PHLDB1 SNP (rs67307131) and NFPA risk.
• The 'C/T' genotype of rs67307131 demonstrated a higher odds ratio (OR=2.39) and a stronger association (P=0.00002).
• Functional analysis predicted rs67307131 to be a CpG site and copy number variant, potentially influencing disease susceptibility.

Conclusions:

• Genetic variations in PHLDB1 may be associated with the risk of NFPA.
• This study is the first to report an association between PHLDB1 variants and NFPA.
• Further research is warranted to confirm the impact of rs67307131 on NFPA susceptibility.